Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide in Pediatric Relapsing Multiple Sclerosis (TERIKIDS)
NCT02201108Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2014
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 22
01
Overview
A Phase 3 trial of teriflunomide in multiple sclerosis (MS), sponsored by Sanofi. Started Jul 2014; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02201108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02201108.